Riviera Biotech at the Bioprom 2026 International Forum
The decision to resume production of Baliz-2 is due to high demand from specialists and patients—the company is ready to scale up production to ensure product availability.
Work on developing Baliz-2 was initiated by Alexey Yakovlevich Shurygin, Doctor of Biological Sciences, Professor, and Honored Scientist of Kuban, in the late 1960s. After conducting preclinical and clinical studies and obtaining all necessary approvals for industrial production and clinical use, production of the drug began in 1991.
For its high therapeutic efficacy and lack of side effects, Baliz-2 was awarded a gold medal at the Brno-Geneva World Exhibition in 1988. It also received three gold medals at exhibitions in Moscow, St. Petersburg, and Nizhny Novgorod in 2001 and 2004. Baliz has no complete analogues in Russia or worldwide.
Action of the active ingredients:
- Antibacterial: Comenic acid has a pronounced bactericidal effect against staphylococci, Proteus, Pseudomonas aeruginosa, and other bacteria.
- Accelerated regeneration without the formation of keloid scars by stimulating natural reparative processes.
- Antioxidant: After an injury, immunity, including local immunity, is weakened. This increases the risk of cell damage by free radicals, which can lead to a delay in the healing process of an abrasion or wound.
The company's key products were showcased at the stand:
- the "Urolife" line,
- "Fitoural" gel,
- the "Prostenol" line,
- the bioactive complex "For Men's Reproductive Health",
- "Esofagel" suspension.
The exhibit generated interest among the professional community, and business meetings allowed for the identification of new areas of collaboration.
Экспозиция нашей компании вызвала значительный интерес у посетителей выставки — специалистов фармацевтической и медицинской отраслей, представителей дистрибьюторских сетей и партнёров. На стенде проходили предметные обсуждения характеристик продуктов, возможностей их применения, а также перспектив дальнейшего сотрудничества.
